Novo Nordisk says Canada will hit semaglutide sales as patents expire
Novo Nordisk says the expiration of its patents for some semaglutide GLP-1 drug treatments in markets like Canada will result in more generics and hurt sales.
#sales #patents #generics #Canada #Consumer #Health
https://globalnews.ca/news/11652345/novo-nordisk-generic-semaglutide-outlook/